Tevogen regains Nasdaq $15M listing compliance
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Tevogen Inc. (TVGN) stated that on September 9, 2026 it received written notice from Nasdaq that it has regained compliance with the $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) for continued listing on the Nasdaq Global Market. Nasdaq informed the company that the compliance matter is now closed.
Positive
- Nasdaq confirmed that Tevogen Inc. has regained compliance with the $15 million minimum market value of publicly held shares requirement, closing the listing compliance matter and supporting its continued trading on the Nasdaq Global Market.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Minimum market value of publicly held shares requirement: $15 million
Common Stock par value: $0.0001 per share
Warrant exercise price: $575.00 per share
3 metrics
Minimum market value of publicly held shares requirement
$15 million
Nasdaq Listing Rule 5450(b)(2&3)(C) threshold for continued listing
Common Stock par value
$0.0001 per share
Par value of Tevogen Inc. common stock listed on Nasdaq
Warrant exercise price
$575.00 per share
Exercise price for Tevogen Inc. warrants listed under symbol TVGNW
Key Terms
market value of publicly held shares, Nasdaq Listing Rule 5450(b)(2&3)(C), Nasdaq Global Market, emerging growth company
4 terms
Nasdaq Listing Rule 5450(b)(2&3)(C) regulatory
"requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) for continued listing"
Nasdaq Global Market market
"requirement ... for continued listing on The Nasdaq Global Market"
The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq compliance update did Tevogen Inc. (TVGN) announce?
Tevogen Inc. announced that Nasdaq notified the company on September 9, 2026 that it has regained compliance with the $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) for continued listing on the Nasdaq Global Market.
What specific Nasdaq listing rule now applies to Tevogen Inc. (TVGN)?
Nasdaq stated that Tevogen Inc. is in compliance with Nasdaq Listing Rule 5450(b)(2&3)(C), which requires a $15 million minimum market value of publicly held shares for continued listing on the Nasdaq Global Market.
Is the Nasdaq compliance issue for Tevogen Inc. (TVGN) resolved?
Yes. Nasdaq informed Tevogen Inc. that it has regained compliance with the $15 million market value of publicly held shares requirement and that the matter is now closed regarding its continued listing on the Nasdaq Global Market.
On what date did Tevogen Inc. (TVGN) receive Nasdaq’s compliance notice?
Tevogen Inc. received Nasdaq’s written notice on September 9, 2026, confirming that the company had regained compliance with the $15 million minimum market value of publicly held shares listing requirement for the Nasdaq Global Market.
What securities of Tevogen Inc. (TVGN) are listed on Nasdaq?
Tevogen Inc. lists its Common Stock, par value $0.0001 per share, under the symbol TVGN and its warrants, exercisable at $575.00 per share, under the symbol TVGNW on the Nasdaq Stock Market LLC.
AI-generated analysis. How Rhea-AI works. Not financial advice.
